Clinical characteristics and long-term clinical outcomes of Japanese heart failure patients with preserved versus reduced left ventricular ejection fraction: A prospective cohort of Shinken Database 2004-2011

Journal of Cardiology

Volumn 62, Issue 2, 2013, Pages 102-109

  Kaneko, Hidehiro ^a   Suzuki, Shinya ^a   Yajima, Junji ^a   Oikawa, Yuji ^a   Sagara, Koichi ^a   Otsuka, Takayuki ^a   Matsuno, Shunsuke ^a   Kano, Hiroto ^a   Uejima, Tokuhisa ^a   Koike, Akira ^a   Nagashima, Kazuyuki ^a   Kirigaya, Hajime ^a   Sawada, Hitoshi ^a   Aizawa, Tadanori ^a   Yamashita, Takeshi ^a  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

Author keywords

Heart failure; Japanese; Preserved ejection fraction; Prognosis

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE; AGED; ANEMIA; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SEX DIFFERENCE; TREATMENT OUTCOME;

HEART FAILURE; JAPANESE; PRESERVED EJECTION FRACTION; PROGNOSIS;

AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CAUSE OF DEATH; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEX FACTORS; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84880131614     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.03.013     Document Type: Article

References (30)

1. Shiba N., Shimokawa H. Chronic heart failure in Japan: implications of the CHART studies. Vasc Health Risk Manage 2008, 4:103-113.
2. Tsutsui H., Tsuchihashi M., Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol 2001, 88:530-533.
3. Ramadan M.M., Okura Y., Ohno Y., Suzuki K., Taneda K., Hoyano M., Hao K., Kimura S., Kodama M., Aizawa Y. Comparative analysis of systolic and isolated diastolic dysfunction: Sado Heart Failure Study. Int Heart J 2008, 49:459-469.
4. Tsuchihashi-Makaya M., Hamaguchi S., Kinugawa S., Yokota T., Goto D., Yokoshiki H., Kato N., Takeshita A., Tsutsui H. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009, 73:1893-1900. JCARE-CARD Investigators.
5. Suzuki S., Yamashita T., Ohtsuka T., Sagara K., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Ogasawara K., Sawada H., Aizawa T. Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004. Circ J 2008, 72:914-920.
6. Kaneko H., Koike A., Senoo K., Tanaka S., Suzuki S., Nagayama O., Sagara K., Otsuka T., Matsuno S., Funada R., Uejima T., Oikawa Y., Yajima J., Nagashima K., Kirigaya H., et al. Role of cardiopulmonary dysfunction and left atrial remodeling in development of acute decompensated heart failure in chronic heart failure with preserved left ventricular ejection fraction. J Cardiol 2012, 59:359-365.
7. Goda A., Yamashita T., Suzuki S., Ohtsuka T., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Sagara K., Ogasawara K., Isobe M., Sawada H., Aizawa T. Heart failure with preserved versus reduced left ventricular systolic function: a prospective cohort of Shinken Database 2004-2005. J Cardiol 2010, 55:108-116.
8. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., Yamagata K., Tomino Y., Yokoyama H., Hishida A. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992. Collaborators developing the Japanese equation for estimated GFR.
9. Tonelli M., Jose P., Curhan G., Sacks F., Braunwald E., Pfeffer M. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ 2006, 332:1426.
10. Roger V.L., Weston S.A., Redfield M.M., Hellermann-Homan J.P., Killian J., Yawn B.P., Jacobsen S.J. Trends in heart failure incidence and survival in a community-based population. JAMA 2004, 292:344-350.
11. Owan T.E., Hodge D.O., Herges R.M., Jacobsen S.J., Roger V.L., Redfield M.M. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355:251-259.
12. Bhatia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A., Gong Y., Liu P.P. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006, 355:260-269.
13. Redfield M.M., Jacobsen S.J., Burnett J.C., Mahoney D.W., Bailey K.R., Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003, 289:194-202.
14. Devereux R.B., Roman M.J., Liu J.E., Welty T.K., Lee E.T., Rodeheffer R., Fabsitz R.R., Howard B.V. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol 2000, 86:1090-1096.
15. Kupari M., Lindroos M., Iivanainen A.M., Heikkila J., Tilvis R. Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study. J Intern Med 1997, 241:387-394.
16. Malki Q., Sharma N.D., Afzal A., Ananthsubramaniam K., Abbas A., Jacobson G., Jafri S. Clinical presentation, hospital length of stay, and readmission rate in patients with heart failure with preserved and decreased left ventricular systolic function. Clin Cardiol 2002, 25:149-152.
17. Cohen-Solal A., Desnos M., Delahaye F., Emeriau J.P., Hanania G. A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society. Eur Heart J 2000, 21:763-769.
18. Masoudi F.A., Havranek E.P., Smith G., Fish R.H., Steiner J.F., Ordin D.L., Krumholz H.M. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2003, 41:217-223.
19. Smith G.L., Masoudi F.A., Vaccarino V., Radford M.J., Krumholz H.M. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 2003, 41:1510-1518.
20. Lenzen M.J., Scholte op Reimer W.J., Boersma E., Vantrimpont P.J., Follath F., Swedberg K., Cleland J., Komajda M. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 2004, 25:1214-1220.
21. Senni M., Redfield M.M. Heart failure with preserved systolic function. A different natural history?. J Am Coll Cardiol 2001, 38:1277-1282.
22. Solomon S.D., Anavekar N., Skali H., McMurray J.J., Swedberg K., Yusuf S., Granger C.B., Michelson E.L., Wang D., Pocock S., Pfeffer M.A. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 2005, 112:3738-3744. Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators.
23. Senni M., Tribouilloy C.M., Rodeheffer R.J., Jacobsen S.J., Evans J.M., Bailey K.R., Redfield M.M. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998, 98:2282-2289.
24. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987, 316:1429-1435.
25. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991, 325:293-302.
26. Anand I., McMurray J.J., Whitmore J., Warren M., Pham A., McCamish M.A., Burton P.B. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004, 110:149-154.
27. Shiba N., Matsuki M., Takahashi J., Tada T., Watanabe J., Shimokawa H. Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure. Circ J 2008, 72:173-178.
28. Go A.S., Yang J., Ackerson L.M., Lepper K., Robbins S., Massie B.M., Shlipak M.G. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 2006, 113:2713-2723.
29. Hosoda J., Ishikawa T., Matsushita K., Matsumoto K., Kimura Y., Miyamoto M., Ogawa H., Takamura T., Sugano T., Ishigami T., Uchino K., Kimura K., Umemura S. Impact of renal insufficiency on long-term clinical outcome in patients with heart failure treated by cardiac resynchronization therapy. J Cardiol 2012, 60:301-305.
30. Bettencourt P., Ferreira A., Dias P., Pimenta J., Frioes F., Martins L., Cerqueira-Gomes M. Predictors of prognosis in patients with stable mild to moderate heart failure. J Card Fail 2000, 6:306-313.